Gilde Healthcare
Gilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.
Business Model: B2B
Revenue: $6.7M
Employees: 11-50
Rankings
Detailed Gilde Healthcare Information
Geographic Data
Address: 222 Third Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$2B
Social
Twitter
Linkedin
Crunchbase
Metrics
3,574,908Website Global Rank
3,806Website Monthly Traffic
Twitter Followers
Description
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture &a; growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Contact Phone:
+18579990339
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2011 | VerzuimVitaal | Private Equity Round | - |
| 12/2007 | Ascendis Pharma | Series A | 25.7M |
| 12/2012 | Pharmaline | Private Equity Round | - |
| 1/2004 | Evotec | Venture Round | - |
| 12/2015 | BionX™ Medical Technologies | Series E | 0 |
| 1/2006 | Symphogen | Series D | 0 |
| 8/2007 | FlowCardia | Series C | 0 |
| 6/2012 | Santaris Pharma | Venture Round | 12M |
| 6/2022 | Ablative Solutions | Series D | 0 |
| 7/2016 | Nightbalance | Series B | 0 |
| 3/2023 | Shoulder Innovations | Series D | 0 |
| 1/2023 | Volta Medical | Series B | 0 |
| 5/2019 | Vesper Medical | Venture Round | 0 |
| 1/2002 | Innate Pharma | Series B | 17.8M |
| 12/2007 | Santaris Pharma | Series C | 30M |
| 4/2004 | Ablynx | Series B | 30M |
| 3/2023 | Noema Pharma | Series B | 0 |
| 5/2012 | Agendia | Private Equity Round | 65M |
| 1/2021 | Volta Medical | Series A | 0 |
| 3/2017 | Moximed | Series C | 50M |
| 10/2012 | Definiens | Venture Round | 0 |
| 4/2014 | Vapotherm | Series B | 0 |
| 11/2011 | Inova Labs | Series B | 0 |
| 4/2006 | Chroma Therapeutics | Series C | 53M |
| 9/2018 | Vapotherm | Series D | 0 |
| 7/2008 | BG Medicine | Series D | 40M |
| 7/2020 | Withings | Series B | 0 |
| 9/2014 | AM Pharma | Series E | 15.8M |
| 6/2019 | SANIFIT | Series D | 0 |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 65M |
| 11/2003 | Roche Glycart | Series A | 13.6M |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 0 |
| 2/2022 | Splice Bio | Series A | 0 |
| 1/2015 | Novicare | Private Equity Round | - |
| 4/2021 | LUMICKS | Series D | 0 |
| 10/2014 | Levicept | Series A | 16.1M |
| 7/2019 | AM Pharma | Series F | 130.1M |
| 6/2015 | Lumeon | Series B | 0 |
| 9/2015 | SANIFIT | Series C | 0 |
| 9/2002 | Ablynx | Series A | 4.9M |
| 7/2020 | Eargo | Series E | 0 |
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 10/2009 | MTM Laboratories | Series C | 57.1M |
| 4/2023 | ADCendo | Series A | 0 |
| 8/2020 | Lumeon | Series D | 0 |
| 8/2011 | ProFibrix | Series B | 10.6M |
| 1/2012 | Moximed | Venture Round | 1.8M |
| 9/2013 | Acacia Pharma | Series B | 23.5M |
| 3/2023 | FIRE1 | Venture Round | 0 |
| 1/2001 | Galapagos | Venture Round | - |
| 8/2009 | ProFibrix | Series B | 11.4M |
| 1/2022 | Big Health | Series C | 0 |
| 2/2022 | Nalu Medical | Venture Round | 0 |
| 5/2012 | Prosonix | Series B | 0 |
| 1/2017 | LUMICKS | Series A | - |
| 9/2012 | BionX™ Medical Technologies | Series D | 0 |
| 6/2020 | Big Health | Series B | 39M |
| 1/2016 | Moximed | Series B | 12.6M |
| 2/2007 | Symphogen | Venture Round | 6.5M |
| 3/2018 | Inari Medical | Series C | 20.9M |
| 3/2016 | NIZO | Private Equity Round | - |
| 3/2021 | Amphista Therapeutics | Series B | 0 |
| 12/2020 | Noema Pharma | Series A | 60M |
| 4/2021 | ADCendo | Series A | 61.8M |
| 7/2011 | Prosonix | Series B | 0 |
| 11/2013 | Sapiens Steering Brain Stimulation | Series C | 23M |
| 5/2018 | Lava Therapeutics | Series A | 18.7M |
| 5/2015 | Moximed | Series B | 33M |
| 3/2011 | Acacia Pharma | Series A | 10M |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 7/2021 | Spire Health | Venture Round | 0 |
| 9/2020 | Lava Therapeutics | Series C | 83M |
| 5/2007 | Conatus Pharmaceuticals | Series A | 22M |
| 7/2015 | Vapotherm | Series C | 0 |
| 5/2017 | Vapotherm | Series D | 0 |
| 10/2002 | Pieris AG | Series A | 0 |
| 4/2016 | STAT-Dx | Series C | 0 |
| 8/2007 | Agendia | Series D | 34M |
| 9/2009 | Agendia | Series E | 23M |
| 1/2018 | FIRE1 | Series C | 49.6M |
| 12/2018 | Lumeon | Series C | 0 |
| 1/2019 | Ablative Solutions | Series D | 0 |
| 7/2020 | CVRx | Private Equity Round | 0 |
| 3/2017 | Breath Therapeutics | Series A | 45.9M |
| 3/2020 | AM Pharma | Venture Round | 25.4M |
| 8/2019 | CVRx | Series G | 93M |
| 3/2023 | GT Medical Technologies | Series C | 0 |
| 6/2014 | Definiens | Venture Round | 0 |
| 6/2006 | Agendia | Series C | - |
| 11/2010 | MTM Laboratories | Series C | 9.7M |
| 11/2011 | Fysius Rugexperts | Private Equity Round | - |
| 7/2017 | Axonics Modulation Technologies | Series C | 20.5M |
| 10/2010 | Stepping Stones Home &a; Care | Private Equity Round | - |
| 2/2019 | Calypso Biotech | Series A | 22.7M |
| 6/2015 | Zetacom | Private Equity Round | - |
| 4/2018 | Axonics Modulation Technologies | Series C | 40M |
| 8/2022 | Moximed | Series C | 0 |
| 9/2021 | Calypso Biotech | Series A | 0 |
| 7/2016 | Nyxoah | Series B | 19.9M |
| 10/2019 | Draupnir Bio | Venture Round | 33M |
| 8/2006 | Ablynx | Series C | 50M |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 0 |
| 4/2023 | ADCendo | Series A | 0 |
| 3/2023 | GT Medical Technologies | Series C | 0 |
| 3/2023 | FIRE1 | Venture Round | 0 |
| 3/2023 | Noema Pharma | Series B | 0 |
| 3/2023 | Shoulder Innovations | Series D | 0 |
| 1/2023 | Volta Medical | Series B | 0 |
| 8/2022 | Moximed | Series C | 0 |
| 6/2022 | Ablative Solutions | Series D | 0 |
| 2/2022 | Nalu Medical | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
